Proposed remedy to chronic back pain among dermatology residents - 16/07/14
Funding sources: None. |
|
Disclosures: Dr Brodell has received honoraria from Allergan, Galderma, 3M/Graceway Pharmaceuticals, GlaxoSmithKline/Stiefel, Dermik/BenzaClin, Novartis Pharmaceuticals, Sanofi-Aventis, Medicis, PharmaDerm, a division of Nycomed US, and Veregen. Dr Brodell has received consultant fees from Galderma Laboratories, LP, Medicis, Dow Pharmaceutical Sciences, and Promius. Dr Brodell serves on advisory boards for Dow Pharmaceutical Sciences and Nycomed US, and has participated in clinical trials for Genentech, Galderma, Abbott Laboratories, and Dow Pharmaceutical Sciences. Drs Casamiquela and Saul have no conflicts to declare. |
|
Conflicts of interest: None declared. |
Vol 71 - N° 2
P. 386-387 - août 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?